{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["24(1)"],"submitter":["Cartlidge MK"],"pubmed_abstract":["<h4>Background</h4>Drugs used to treat rheumatic disease are associated with pneumotoxicity (drug-induced lung disease), but little is known about associated risk factors.<h4>Aim</h4>To determine expert physician-perceived risk factors for developing pneumotoxicity in patients with rheumatologic conditions.<h4>Methods</h4>A modified international 3-tier Delphi exercise was performed. Tier 1 determined patient and drug variables that physicians perceive to be risk factors. Tier 2 determined degree of risk associated with the Tier-1 derived variables. Tier 3 aimed to internally validate and stratify exemplar cases into risk categories.<h4>Results</h4>134 pulmonologists and 49 rheumatologists responded to Tier 1;157 physicians completed all tiers. Perceived risk factors included: drug type; h"],"journal":["BMC pulmonary medicine"],"pagination":["547"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11529426"],"repository":["biostudies-literature"],"pubmed_title":["A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease."],"pmcid":["PMC11529426"],"pubmed_authors":["Johannson KA","Busaid NA","Hyldgaard C","Lipchik RJ","Corte TJ","John L","Matsuda T","Nossent EJ","Tanino Y","Solomon JJ","Perch M","Blum HC","Bendstrup E","Ross AD","Foti R","Brown KK","Chaigne B","Bilaceroglu S","Dhasmana DJ","Nunes MS","Stewart G","Sebastiani M","Hysa E","Jones MG","Eiger G","Grainger R","Derrett-Smith E","Naclerio C","Radzikowska E","Gheorghiu AM","Papanikolaou IC","Assaya D","Maher TM","Sehga S","O'Beirne SL","Antin-Ozerkis D","Dieude P","Rivera-Ortega P","Russell T","Nunes H","Mukherjee S","Brito de Araujo D","Kiyan E","Myall KJ","Ramirez MTR","Perkovic D","Hajari Case A","Ceribelli A","McRorie E","Nicol L","Garcia Martos A","Manfredi A","Borie R","Amaral AF","Confalonieri P","Kelly C","Ferreira P","Guillen A","Godoy","Castillo D","Tomii K","Chalmers GW","Turner AM","Wuyts WA","Luckhardt T","Kalyoncu AF","Chaudhuri N","Izumi S","Vikse J","Wilsher ML","Grazzini S","Iudici M","Agrawal A","Kabasakal Y","Montoya SF","Al-Farttoosi A","Baresic M","Selvi E","Rosato E","Berlengiero V","Morovic-Vergles J","Selva-O'Callaghan A","Shifren A","Benucci M","Delobbe A","Keshavan V","Gabrielli A","Camus P","Spencer LG","Carreira PE","Jones RM","Saunders P","Balbir-Gurman A","Davidsen JR","Campainha S","Waseda Y","Kalluri M","Cobilinschi C","Avdeev S","Patil S","Bernardino V","Chaudhury N","Walker UA","Toma CL","Novelli L","Balestro E","Alfaro T","Devi HJG","Wijsenbeek M","Golla J","van der Lee I","Launay D","Rednic S","Drakopanagiotakis F","Crestani B","Patel DC","Muller C","Garzanova L","Judge EP","Padilla ML","Walsh SLF","Gardiner PV","Chai GT","Koduri GM","Scarlata S","Gudmundsson G","Khanna D","Salinas M","Mogulkoc N","MdC V","Vicens-Zygmunt V","Lopez Miguel P","Ryerson CJ","Low SY","Fretheim H","Parfrey H","Campochiaro C","Fahim A","Culver DEL","Stebbings SM","Castro HM","Stewart GA","Reza Beiga DM","Crawshaw A","Conticini E","Bennett D","Juge PA","Carbone RG","Saiton S","Hirani N","Carty SM","Kolb M","Cameli P","Cartlidge MK","PASSWRD participants","Kah-Lai Leong C","Chua F","Marovic KF","Sulli A","Dzhus M","Nicol LM","Garcia Gonzalez E","Highland KB","Robles-Perez A"],"additional_accession":[]},"is_claimable":false,"name":"A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease.","description":"<h4>Background</h4>Drugs used to treat rheumatic disease are associated with pneumotoxicity (drug-induced lung disease), but little is known about associated risk factors.<h4>Aim</h4>To determine expert physician-perceived risk factors for developing pneumotoxicity in patients with rheumatologic conditions.<h4>Methods</h4>A modified international 3-tier Delphi exercise was performed. Tier 1 determined patient and drug variables that physicians perceive to be risk factors. Tier 2 determined degree of risk associated with the Tier-1 derived variables. Tier 3 aimed to internally validate and stratify exemplar cases into risk categories.<h4>Results</h4>134 pulmonologists and 49 rheumatologists responded to Tier 1;157 physicians completed all tiers. Perceived risk factors included: drug type; h","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Oct","modification":"2025-04-05T09:14:19.829Z","creation":"2025-04-05T09:14:19.829Z"},"accession":"S-EPMC11529426","cross_references":{"pubmed":["39482644"],"doi":["10.1186/s12890-024-03287-0"]}}